Tony Villiotti, who lives in Pennsylvania, was diagnosed with metabolic dysfunction-associated steatotic liver disease (MASLD) in 2005, which progressed to metabolic-associated steatohepatitis by 2014. He reflects on the questions he wishes he’d asked earlier about MASLD progression.

Two questions, really.

One, you know, “What’s next? What happens if this disease gets worse?” You know, “What lies ahead down the road for me if I ignore it or don’t take any precautions?”

The second question would be, “What can I do to either stop the progression of the disease or to reverse the disease?”

MASLD is a reversible disease. If you take the proper steps — lose weight, increase exercise, and so forth. So what the patient ought to be asking are the questions that would help them fight or reverse the disease.